HepSYS LabEx is dedicated to researching viral hepatitis and liver diseases caused by viruses. It adopts an interdisciplinary strategy to gain a comprehensive understanding of the intricate interplay between viruses and their host, as well as the progression of diseases. Its primary goal is to develop effective antiviral treatments and vaccines.
The core consortium of HepSYS LabEx comprises members from the Research Unit U1110 (Inserm-Unistra), including faculty members, senior and junior researchers, clinicians, as well as PhD and undergraduate students. Additionally, the lab maintains a collaborative research alliance with esteemed scientists and clinicians globally.
By fostering established partnerships with industry stakeholders, HepSYS LabEx aims to cultivate strategic and financial collaborations for the advancement of novel antiviral medications.